These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 38652179)

  • 1. Involvement of the glymphatic/meningeal lymphatic system in Alzheimer's disease: insights into proteostasis and future directions.
    Yamada K; Iwatsubo T
    Cell Mol Life Sci; 2024 Apr; 81(1):192. PubMed ID: 38652179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer's disease: an updated overview of nonpharmacological therapies.
    Formolo DA; Yu J; Lin K; Tsang HWH; Ou H; Kranz GS; Yau SY
    Mol Neurodegener; 2023 Apr; 18(1):26. PubMed ID: 37081555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connections Between Amyloid Beta and the Meningeal Lymphatics As a Possible Route for Clearance and Therapeutics.
    Dupont G; Iwanaga J; Yilmaz E; Tubbs RS
    Lymphat Res Biol; 2020 Feb; 18(1):2-6. PubMed ID: 31433264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glymphatic function and clearance of tau in an Alzheimer's disease model.
    Harrison IF; Ismail O; Machhada A; Colgan N; Ohene Y; Nahavandi P; Ahmed Z; Fisher A; Meftah S; Murray TK; Ottersen OP; Nagelhus EA; O'Neill MJ; Wells JA; Lythgoe MF
    Brain; 2020 Aug; 143(8):2576-2593. PubMed ID: 32705145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease.
    Chachaj A; Gąsiorowski K; Szuba A; Sieradzki A; Leszek J
    Curr Neuropharmacol; 2023; 21(2):380-391. PubMed ID: 35410605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of dural sinus-associated lymphatic vasculature in human Alzheimer's dementia subjects.
    Goodman JR; Adham ZO; Woltjer RL; Lund AW; Iliff JJ
    Brain Behav Immun; 2018 Oct; 73():34-40. PubMed ID: 30055243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yuanzhi powder facilitated Aβ clearance in APP/PS1 mice: Target to the drainage of glymphatic system and meningeal lymphatic vessels.
    Li J; Hao Y; Wang S; Li W; Yue S; Duan X; Yang Y; Li B
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117195. PubMed ID: 37717839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework.
    Mentis AA; Dardiotis E; Chrousos GP
    Mol Psychiatry; 2021 Apr; 26(4):1075-1097. PubMed ID: 32355332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of aquaporin-4 aggravates brain pathology after blocking of the meningeal lymphatic drainage.
    Cao X; Xu H; Feng W; Su D; Xiao M
    Brain Res Bull; 2018 Oct; 143():83-96. PubMed ID: 30347264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus.
    Reeves BC; Karimy JK; Kundishora AJ; Mestre H; Cerci HM; Matouk C; Alper SL; Lundgaard I; Nedergaard M; Kahle KT
    Trends Mol Med; 2020 Mar; 26(3):285-295. PubMed ID: 31959516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease.
    Li Y; Zhang J; Wan J; Liu A; Sun J
    Biomed Pharmacother; 2020 Dec; 132():110887. PubMed ID: 33254429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of Meningeal Lymphatic Vessels in Alzheimer's Disease.
    Guo X; Zhang G; Peng Q; Huang L; Zhang Z; Zhang Z
    J Alzheimers Dis; 2023; 94(s1):S355-S366. PubMed ID: 36683509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photobiomodulation Therapy and the Glymphatic System: Promising Applications for Augmenting the Brain Lymphatic Drainage System.
    Salehpour F; Khademi M; Bragin DE; DiDuro JO
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glymphatic pathway in neurological disorders.
    Rasmussen MK; Mestre H; Nedergaard M
    Lancet Neurol; 2018 Nov; 17(11):1016-1024. PubMed ID: 30353860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borneol-driven meningeal lymphatic drainage clears amyloid-β peptide to attenuate Alzheimer-like phenotype in mice.
    Wu Y; Zhang T; Li X; Wei Y; Li X; Wang S; Liu J; Li D; Wang S; Ye T
    Theranostics; 2023; 13(1):106-124. PubMed ID: 36593948
    [No Abstract]   [Full Text] [Related]  

  • 16. Current views on meningeal lymphatics and immunity in aging and Alzheimer's disease.
    Rego S; Sanchez G; Da Mesquita S
    Mol Neurodegener; 2023 Aug; 18(1):55. PubMed ID: 37580702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
    Cheng Y; Tian DY; Wang YJ
    Transl Neurodegener; 2020 May; 9(1):16. PubMed ID: 32381118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of glymphatic-lymphatic drainage of beta-amyloid by focused ultrasound in Alzheimer's disease model.
    Lee Y; Choi Y; Park EJ; Kwon S; Kim H; Lee JY; Lee DS
    Sci Rep; 2020 Sep; 10(1):16144. PubMed ID: 32999351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.
    Louveau A; Plog BA; Antila S; Alitalo K; Nedergaard M; Kipnis J
    J Clin Invest; 2017 Sep; 127(9):3210-3219. PubMed ID: 28862640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.
    Xin SH; Tan L; Cao X; Yu JT; Tan L
    Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.